-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q3 2016 to Q4 2023.
- Apellis Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending December 31, 2023 was $142M, a 68% increase year-over-year.
- Apellis Pharmaceuticals, Inc. General and Administrative Expense for the twelve months ending December 31, 2023 was $501M, a 80.7% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual General and Administrative Expense for 2023 was $501M, a 80.7% increase from 2022.
- Apellis Pharmaceuticals, Inc. annual General and Administrative Expense for 2022 was $277M, a 56.8% increase from 2021.
- Apellis Pharmaceuticals, Inc. annual General and Administrative Expense for 2021 was $177M, a 26.8% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)